Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

“We are trying to maintain patient programs, but we need funding to do it and that is why the walk is so important," said ...

HealthDay News — For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20 percent of patients and associated factors include younger age ...

In standing together, we can ensure that Mercédi’s fight with lupus is not her fight alone. A community mobilised by empathy ...

People with lupus are more likely to develop asthma than those without the autoimmune condition. However, the exact association between both conditions is still unclear. Lupus is a chronic ...

[20] The most common cutaneous manifestations of drug-induced allergic reactions are a generalized exanthema, urticaria and angioedema. The most severe forms are Stevens–Johnson syndrome and ...

The drug in question is cenerimod, a S1P1 receptor modulator currently in phase 3 trials for systemic lupus erythematosus (SLE). The latest licensing deal forms part of a broader restructuring of ...

BACKGROUND: Statins have been increasingly associated with drug-induced autoimmune reactions, including lupus erythematosus. OBJECTIVE: To identify and determine the clinical and biological ...

Doctors refer to hair loss that occurs as a side effect of medication as drug-induced alopecia. Hair loss can be a side effect of many different medications, such as those for chemotherapy.

Lupus is a chronic autoimmune disease that can cause severe and irreversible damage to vital organs, including the lungs, kidneys, heart, and liver. The disease triggers widespread inflammation ...

The U.S. Food and Drug Administration (FDA) approved anifrolumab in 2021 for treatment of systemic lupus erythematosus, the most common form of lupus. Anifrolumab Is a monoclonal antibody that works ...